Jörg Elliesen - Concepedia

Author

Jörg Elliesen

Bayer (Germany)

Also Known As

Jörg Elliesen, Jörg Elliesen

Publications

385

Citations

H-Index

Concepts

All Affiliations

Bayer (Germany)University of Manchester University of Bologna Canadian Women's Health Network Martin Luther University Halle-Wittenberg

About

Jörg Elliesen is an author at Bayer (Germany) specializing in obstetrics, women's health, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	126
2	Obstetrics	2	2	126
3	Public Health	1	1	81
4	Endocrinology	1	1	81
5	Health Policy	1	1	81

Jörg Elliesen

Publications

384

Citations

H-Index

Page 1

	Year	Citations
Male Hormonal Contraception: A Double-Blind, Placebo-Controlled Study Ellen Mommers, Wendy M. Kersemaekers, Jörg Elliesen, The Journal of Clinical Endocrinology & Metabolism	2008	123
10<sup>th</sup> Summit Meeting Consensus: Recommendations for Regulatory Approval for Hormonal Male Contraception Pertti Aaltonen, John K. Amory, Richard A. Anderson, Journal of Andrology SpermatogenesisReproductive SciencesContraceptive UseHormonal ContraceptiveFertility	2007	81
Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study Jeffrey T. Jensen, Sona Grossova Garie, Dietmar Trummer, Contraception Us WomenMedicineFlexible Extended RegimenGynecologyPharmacotherapy	2012	45
Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study Christine Klipping, Ingrid Duijkers, Michel Fortier, Journal of Family Planning and Reproductive Health Care	2012	38
Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study T. Strowitzki, Bodo Kirsch, Jörg Elliesen Journal of Family Planning and Reproductive Health Care	2012	35
Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study Christine Klipping, Ingrid Duijkers, Michel Fortier, Journal of Family Planning and Reproductive Health Care	2012	29
Efficacy and safety of a flexible extended regimen of ethinylestradiol/drospirenone for the treatment of dysmenorrhea: a multicenter, randomized, open-label, active-controlled study Mikio Momoeda, Masami Kondo, Jörg Elliesen, International Journal of Women s Health	2017	22
Adherence with ethinylestradiol 20 &micro;g/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study Inka Wiegratz, Jörg Elliesen, Anna Maria Paoletti, International Journal of Women s Health	2015	11

Page 1